Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Borison

Showing results (11-20 of 64) with videos related to

Pageof 7
Sort By:
Transactions of the American Neurological Association|January 1, 1979
Kainic acid animal model predicts therapeutic agents in Huntington's choreaR L Borison, B I Diamond
JAMA|August 27, 1982
Lithium and lupuslike syndromeV R Shukla, R L Borison
Brain Research Bulletin|August 1, 1983
Regional selectivity of neuroleptic drugs: an argument for site specificityR L Borison, B I Diamond
Pharmacology|January 1, 1978
A new putative neuroregulator of the extrapyramidal systemB I Diamond, R L Borison
Advances in Biochemical Psychopharmacology|January 1, 1976
2-Phenylethylamine and other adrenergic modulatorsH C Sabelli, R L Borison
Advances in Biochemical Psychopharmacology|January 1, 1980
Anticholinergics promote neuroleptic-induced tardive dyskinesiaR L Borison, B I Diamond
The Journal of Clinical Psychiatry|September 1, 1987
Neuropharmacology of the extrapyramidal systemR L Borison, B I Diamond
Current Psychiatric Therapies|January 1, 1983
Amantadine in Tourette syndromeR L Borison, J M Davis
Biological Psychiatry|April 1, 1978
A new animal model for schizophrenia: interactions with adrenergic mechanismsR L Borison, B I Diamond
Advances in Biochemical Psychopharmacology|January 1, 1982
Regulatory peptides in animal paradigms of neuropsychiatric illnessB I Diamond, R L Borison
Pageof 7

Showing results (11-20 of 64) with videos related to

Sort By:
Pageof 7
Transactions of the American Neurological Association|January 1, 1979
Kainic acid animal model predicts therapeutic agents in Huntington's choreaR L Borison, B I Diamond
JAMA|August 27, 1982
Lithium and lupuslike syndromeV R Shukla, R L Borison
Brain Research Bulletin|August 1, 1983
Regional selectivity of neuroleptic drugs: an argument for site specificityR L Borison, B I Diamond
Pharmacology|January 1, 1978
A new putative neuroregulator of the extrapyramidal systemB I Diamond, R L Borison
Advances in Biochemical Psychopharmacology|January 1, 1976
2-Phenylethylamine and other adrenergic modulatorsH C Sabelli, R L Borison
Advances in Biochemical Psychopharmacology|January 1, 1980
Anticholinergics promote neuroleptic-induced tardive dyskinesiaR L Borison, B I Diamond
The Journal of Clinical Psychiatry|September 1, 1987
Neuropharmacology of the extrapyramidal systemR L Borison, B I Diamond
Current Psychiatric Therapies|January 1, 1983
Amantadine in Tourette syndromeR L Borison, J M Davis
Biological Psychiatry|April 1, 1978
A new animal model for schizophrenia: interactions with adrenergic mechanismsR L Borison, B I Diamond
Advances in Biochemical Psychopharmacology|January 1, 1982
Regulatory peptides in animal paradigms of neuropsychiatric illnessB I Diamond, R L Borison
Pageof 7